期刊文献+

齿状核红核苍白球路易体萎缩一例:临床表型与基因突变分析 被引量:5

Clinical and genetic study of one DRPLA case
下载PDF
导出
摘要 目的报告1例齿状核红核苍白球路易体萎缩(DRPLA)患者的临床特征和基因突变特点。方法采用聚合酶链反应对388例脊髓小脑共济失调患者(234例常染色体显性遗传家系先证者和1 54例散发病例)进行初步筛查,对琼脂糖凝胶电泳中出现2条电泳条带的样品应用荧光标记毛细管电泳基因片段分析方法进行脊髓小脑共济失调致病基因三核苷酸(CAG)重复序列突变检测并精确计数,最后经pUC18-T载体克隆测序验证重复次数达异常范围的样本。结果仅发现1例表现为轻度脊髓小脑共济失调和可疑癫癎发作的女性患者具有DRPLA基因CAG重复扩展突变。基因片段分析2个等位基因的CAG重复次数分别为14和54次,克隆测序重复次数为15和58次。其家系另2例成员均有癫癎发作史,但无明显共济失调表现。19例无异常扩展样本基因片段分析显示CAG重复次数为7~20次,其中9次重复最为常见。结论 DRPLA可能存在临床变异。388例脊髓小脑共济失调患者中仅发现1例DRPLA,说明该病在中国共济失调患者中相对罕见。在重复突变检测过程中,由于高度重复序列可产生局部二级结构,在复制过程中可能会出现DNA聚合酶的滑动,从而导致扩增产物的不忠实,这一问题在基因片段分析和克隆测序中均存在,且后者在操作过程中还可能出现克隆过程的不稳定,因此基于这两种方法的结果需要相互验证。 Objective To investigate the clinical and genetic features of dentatorubralpallidoluysian atrophy (DRPLA). Methods The trinucleotide repeats of spinocerebellar ataxia (SCA) disease genes were detected by polymerase chain reaction (PCR) initially in 388 SCA cases which included 234 cases with autosomal dominant inheritance and 154 sporadic cases. Fragment analysis with laser- induced fluorescence in capillary electrophoresis was performed for the samples with 2 bands detected by agarose gel electrophoresis (AGE). The repeat numbers of the positive or suspicious samples were verified by the pUCI8-T vector cloning and sequencing. Results Based on the 2 methods, the cytosine-adenine- guanine (CAG) repeat expansion of DRPLA gene was detected in one female ease with mild ataxia and suspected seizure. The repeat numbers of the 2 alleles were 14 and 54 by fragment analysis, and 15 and 58 by cloning sequencing. The 2 members of her family had a history of seizure, but no obvious ataxia. The CAG repeat numbers of the other 19 cases without abnormal expansions ranged from 7 to 20, of which 9 was common. Conclusion The patient's atypical manifestations suggests that clinical variation may exist in DRPLA. Only one case of DRPLA is found in 388 SCA cases, indicating that DRPLA may be a relatively rare subtype of SCA in Chinese population. The secondary structure of DNA owing to the highly repetitive sequences will induce DNA polymerase sliding during the amplification, which will reduce the fidelity in DNA replication. This problem exists in both fragment analysis and cloning sequencing. For the latter method, the instability also appears in the process of cloning. Therefore, the repeat numbers need to be mutually verified by the 2 methods.
出处 《中国现代神经疾病杂志》 CAS 2010年第6期637-641,共5页 Chinese Journal of Contemporary Neurology and Neurosurgery
基金 卫生部临床学科重点项目
关键词 基因 三核苷酸重复 突变 脊髓小脑共济失调 Genes Trinucleotide repeats Mutation Spinocerebellar ataxias
  • 相关文献

参考文献21

  • 1Tsuji S.Dentatorubral-pallidoluysian atrophy:clinical aspects and molecular genetics.Adv Neurol,2002,89:231-239.
  • 2Koide R,Ikeuchi T,Onodera O,et al.Unstable expansion of CAG repeat in hereditary dentatorubral-pallidoluysian atrophy (DRPLA).Nat Genet,1994,6:9-13.
  • 3Schols L,Bauer P,Schmidt T,et al.Autosomal dominant cerebellar ataxias:clinical features,genetics,and pathogenesis.Lancet Neurol,2004,3:291-304.
  • 4Alford RL,Margolis RL,Ross CA,et al.Southern analysis for detection of CAG repeat expansions associated with dentatorubral pallidoluysian atrophy.Hum Genet,1997,99:354-356.
  • 5Shimojo Y,Osawa Y,Fukumizu M,et al.Severe infantile dentatorubral pallidoluysian atrophy with extreme expansion of CAG repeats.Neurology,2001,56:277-278.
  • 6Shimizu Y,Yoshida K,Okano T,et al.Regional features of autosomal-dominant cerebellar ataxia in Nagano:clinical and molecular genetic analysis of 86 families.J Hum Genet,2004,49:610-616.
  • 7Vinton A,Fahey MC,O'Brien TJ,et al.Dentatorubral-pallidoluysian atrophy in three generations,with clinical courses from nearly asymptomatic elderly to severe juvenile,in an Australian family of Macedonian descent.Am J Med Genet A,2005,136:201-204.
  • 8宋兴旺,唐北沙,江泓,沈璐,杨茜,廖书胜,李清华,梁晓春,汤建光.中国大陆南方汉族正常人群齿状核红核苍白球路易体萎缩基因三核苷酸重复变异研究[J].中华神经医学杂志,2006,5(9):915-917. 被引量:2
  • 9张爱娟,杨利丽,钟池.齿状核红核苍白球丘脑下部萎缩一家系临床与基因特征[J].中华神经科杂志,2007,40(7):479-481. 被引量:8
  • 10Lin X,Cummings CJ,Zoghbi HY.Expanding our understanding ofpolyglutamine diseases through mouse models.Neuron,1999,24:499.502.

二级参考文献28

  • 1江泓,唐北沙,许波,赵国华,沈璐,汤建光,李清华,夏昆.中国大陆汉族人群SCA各亚型的突变频率分析及SCA6的临床和分子特征[J].中华医学遗传学杂志,2005,22(1):1-4. 被引量:9
  • 2[1]Dürr A,Stevanin G,Cancel G,et al.Spinocerebellar ataxia 3 and Machado-Joseph disease:clinical,molecular,and neuropathological features.Ann Neurol,1996,39:490-499.
  • 3[2]Sekai T,Kawakami H.Machado-Joseph disease:a proposal of spastic paraplegic subtype.Neurology,1996,46:846-847.
  • 4[3]Tuite PJ,Bogaeva EA,St George-Hyslop PH,et al.Dopa-responsive parkinsonism phenotype of Machado-Joseph disease:confirmation of 14q CAG expansion.Ann Neurol,1995,38:684-687.
  • 5[4]Rosenberg RN,Fowler HL.Autosomal dominant motor system disease of the Portuguese:a review.Neurology,1981,31:1124-1126.
  • 6[5]Bressman S.Cenetics of dystonia.J Neural Transm Suppl,2006,(70):489-495.
  • 7[6]Bressman SB.Dystonia:phenotypes and genotypes.Rev Neurol(Paris),2003,159(10 Pt 1):849-856.
  • 8[7]Trost M.Dystonia update.Curr Opin Neurol,2003,16:495-500.
  • 9[8]Maciel P,Gaspar C,DeStefano AL,et al.Correlation between CAG repeat length and clinical features in Machado-Joseph disease.Am J Hum Genet,1995,57:54-61.
  • 10[9]Jardim L Silveira I,Pereira ML,et al..Searching for modulating effects of SCA2,SCA6 and DRPLA CAG tracts on the MachadoJoseph disease(SCA3)phenotype.Acta Neurol Seand,2003,107:211-214.

共引文献18

同被引文献42

  • 1李志超,田增民.脊髓小脑共济失调的研究进展[J].第二军医大学学报,2005,26(6):692-695. 被引量:7
  • 2Sch(o)ls L.Bauer P,Schmidt T,et al.Autosomal,dominant cerebellar ataxias:clinical features,genetics,and pathogenesis.Lancet Neurol,2004,3:291-304.
  • 3Wang L,Tsai CC.Atrophin proteius:an overview of a new class of nuclear receptor corepressors.Nucl Recept Signal,2008,6:E9.
  • 4Shen Y,Peterson AS.Atrophins' emerging roles in development and neurodegenerative disease.Cell Mol Life Sci,2009,66:437-446.
  • 5Zoghbi HY,Orr HT.Glutamine repeats and neurodegeneration.Annu Rev Neurosci,2000,23:217-247.
  • 6Ross CA,Poirier MA.Opinion:what is the role of protein aggregation in neurodegeneration?Nat Rev Mol Cell Biol,2005,6:891-898.
  • 7Takahanhi T,Katatla S,Onodera O.Polyglutamine diseases:where does toxicity come from?What is toxicity?Where are we going?J Mol Cell Biol,2010,2:180-191.
  • 8Ellerhy LM,Andrusiak RL,Wellington CL,et al.Cleavage of atrophin-1 at caspase site aspartic acid 109 modulates cytotoxicity.J Biol Chem,1999,274:8730-8736.
  • 9Okamura-Oho Y,Miyashita T,Nagao K,et al.Dentatorubralpallidoluysian atrophy protein is phosphorylated by C-Jun NH2-terminal kinase.Hum Mol Genet,2003,12:1535-1542.
  • 10Terashima T,Kawai H,Fujitani M,et al.SUMO-1 co-localized with mutant atrophin-1 with expanded polyglutamines accelerates intranuclear aggregation and cell death.Neuroreport,2002,13:2359-2364.

引证文献5

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部